[Effects of sodium arsenite exposure on activation and extracellular matrix secretion of human hepatic stellate cells]

Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Oct 6;52(10):983-987. doi: 10.3760/cma.j.issn.0253-9624.2018.10.004.
[Article in Chinese]

Abstract

Objective: To explore the effects of sodium arsenite (NaAsO(2)) exposure on the activation and extracellular matrix secretion of human hepatic stellate cells, and to provide a theoretical basis for the mechanism study of arsenic induced hepatic fibrosis. Methods: Different doses of NaAsO(2) (0.0, 0.1, 1.0, 10.0, 50.0, 100.0 μmol/L) were exposed to human hepatic stellate cell line (Lx-2) for 24, 48 and 72 huors. CCK-8 assay was used to measure cell viability and IC(50) of NaAsO(2) on Lx-2 was then calculated; According to IC(50) results, 0.000, 1.875, 3.750, 7.500, and 15.000 μmol/L of NaAsO(2) were exposed to Lx-2 cells for 24 hours, besides, 7.500 μmol/L of NaAsO(2) was exposed to Lx-2 cells for 0, 12, 24, 48, and 72 hours, then collected cells and culture supernatant; HSC activation-related protein, including α-smooth muscle actin (α-SMA), and transforming growth factor-β1 (TGF-β1) expression levels were detected by Western blot analysis, the main extracellular matrix including laminin (LN) , hyaluronic acid (HA), collagen Ⅳ (COL-Ⅳ) and procollagen Ⅲ(P Ⅲ NP) secretion level was detected by Elisa assay. Results: CCK-8 assay showed that the cell viability of Lx-2 cells were increased obviously at low doses (≤1.0 μmol/L) of arsenic exposure, especially at 48 and 72 h. In contrast, with the increasing doses of arsenic exposure, the survival rate of Lx-2 cell was decreased gradually, and the survival rate of the high-dose (50, 100 μmol/L) arsenic exposure group at 24, 48 and 72 h were significantly lower than 0.0 μmol/L group, P<0.05. The IC(50) of NaAsO(2) on Lx-2 cells at 24, 48, 72 h were calculated as 72.75, 48.19 and 29.95 μmol/L, respectively; The expression levels of HSC activation-related protein showed that, after treated with 1.875, 3.750, 7.500, 15.000 μmol/L NaAsO(2) for 24 h, α-SMA and TGF-β1 protein level were higher than 0.000 μmol/L group. The increased expression of α-SMA and TGF-β1 protein were most significant in 7.500 μmol/L NaAsO(2) group (P<0.05). In addition, the expression levels of α-SMA and TGF-β1 also showed a time-dependent increasing in Lx-2 cells after treated with 7.500 μmol/L NaAsO(2) for 0, 12, 24, 48 and 72 h; Elisa assay showed that after treated with 1.875, 3.750, 7.500, 15.000 μmol/L NaAsO(2) for 24 h, the secretion levels of HA, LN, COL-Ⅳ and PⅢNP were obvious higher than 0.000 μmol/L group (P<0.05). Moreover, the secretion levels of HA, LN, COL-Ⅳ and P Ⅲ NP also showed a time-dependent increased manner in Lx-2 cells after exposed to 7.500 μmol/L NaAsO(2) for 0, 12, 24, 48 and 72 h (P<0.05). Conclusion: NaAsO(2) exposure to Lx-2 cells can upregulate the expression level of HSC activation-related proteins, induce its further activation, then increase ECM secretion level.

目的: 探讨不同浓度亚砷酸钠(NaAsO(2))暴露对人肝星状细胞活化及主要细胞外基质(ECM)分泌的影响。 方法: 采用不同浓度NaAsO(2)(0.0、0.1、1.0、10.0、50.0、100.0 μmol/L)处理体外培养的人肝星状细胞株(Lx-2)24、48、72 h后,采用细胞增殖毒性检测试剂盒(CCK-8)检测细胞存活率,计算半数抑制浓度(IC(50));根据IC(50)结果,采用0.000、1.875、3.750、7.500、15.000 μmol/L NaAsO(2)处理Lx-2细胞24 h,另以7.500 μmol/L NaAsO(2)处理Lx-2细胞0、12、24、48、72 h,到达处理终点收集细胞沉淀及培养上清。采用Western blot法检测Lx-2细胞活化相关蛋白表达水平,包括α-平滑肌肌动蛋白(α-SMA)和转化生长因子-β1(TGF-β1);ELISA法检测培养上清主要用于ECM分泌水平,包括透明质酸(HA)、层粘连蛋白(LN)、Ⅳ型胶原(COL-IV)、Ⅲ型前胶原氨基端肽(PⅢNP)。 结果: 随NaAsO(2)处理浓度的增加,Lx-2细胞存活率逐渐下降,其中50.0、100.0 μmol/L砷暴露组在24、48和72 h时,细胞存活率较0.0 μmol/L组均明显降低(P<0.05);处理24、48、72 h的IC(50)分别为72.75、48.19和29.95 μmol/L。肝星状细胞活化相关蛋白检测结果发现,1.875、3.750、7.500、15.000 μmol/L NaAsO(2)处理Lx-2细胞24 h后,α-SMA和TGF-β1蛋白表达水平均高于0.000 μmol/L,且在7.500 μmol/L剂量组蛋白表达差异最大(P<0.05)。7.500 μmol/L NaAsO(2)处理Lx-2细胞0、12、24、48、72 h后,α-SMA和TGF-β1蛋白表达水平亦随染毒时间的增加而升高(P<0.05)。ECM分泌水平检测显示,1.875、3.750、7.500、15.000 μmol/L NaAsO(2)处理24 h后,HA、LN、COL-Ⅳ和PⅢNP分泌水平均高于0.000 μmol/L组(P<0.05)。7.500 μmol/L NaAsO(2)处理Lx-2细胞0、12、24、48、72 h后,HA、LN、COL-Ⅳ和PⅢNP分泌水平均高于对照组(P<0.05)。 结论: NaAsO(2)可上调肝星状细胞活化相关蛋白表达,诱导其进一步活化,进而增加细胞外基质分泌水平。.

Keywords: Extracellular matrix; Hepatic stellate cell; Liver; Liver fibrosis; Sodium arsenite.

MeSH terms

  • Arsenites / metabolism*
  • Arsenites / toxicity
  • Environmental Exposure / adverse effects
  • Extracellular Matrix / metabolism*
  • Hepatic Stellate Cells / metabolism*
  • Humans
  • Liver Cirrhosis / chemically induced
  • Sodium Compounds / metabolism*
  • Sodium Compounds / toxicity

Substances

  • Arsenites
  • Sodium Compounds
  • sodium arsenite